PMID- 25276347 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20141003 LR - 20220318 IS - 2047-1440 (Print) IS - 2047-1440 (Electronic) IS - 2047-1440 (Linking) VI - 3 DP - 2014 TI - Factors influencing survival after kidney transplant failure. PG - 18 LID - 10.1186/2047-1440-3-18 [doi] AB - BACKGROUND: The failure of a kidney transplant is now a common reason for initiation of dialysis therapy. Kidney transplant recipients commencing dialysis have greater morbidity and mortality than transplant-naive, incident dialysis patients. This study aimed to identify variables associated with survival after graft failure. METHODS: All recipients of first, deceased donor kidney transplants performed in Northern Ireland between 1986 and 2005 who had a functioning graft at 12 months were included (n = 585). Clinical and blood-derived variables (age, gender, primary renal disease, diabetic status, smoking status, human leukocyte antigen (HLA) mismatch, acute rejection episodes, immunosuppression, cardiovascular disease, graft survival, haemoglobin, albumin, phosphate, C reactive protein, estimated glomerular filtration rate (eGFR), rate of eGFR decline, dialysis modality, and access) were collected prospectively and investigated for association with re-transplantation and survival. The association between re-transplantation and survival was explored by modelling re-transplantation as a time-dependent covariate. RESULTS: Median follow-up time was 12.1 years. Recipients with a failing graft (158/585) demonstrated rapid loss of eGFR prior to graft failure, reducing the time available to plan for alternative renal replacement therapy. Median survival after graft failure was 3.0 years. In multivariate analysis, age and re-transplantation were associated with survival after graft failure. Re-transplantation was associated with an 88% reduction in mortality. CONCLUSIONS: Optimal management of kidney transplant recipients with failing grafts requires early recognition of declining function and proactive preparation for re-transplantation given the substantial survival benefit this confers. The survival benefit associated with re-transplantation persists after prolonged exposure to immunosuppressive therapy. FAU - McCaughan, Jennifer A AU - McCaughan JA AD - Regional Nephrology Unit, Belfast City Hospital, Belfast BT9 7AB, UK ; Nephrology Research Group, Queen's University, Belfast BT9 7AB, UK. FAU - Patterson, Christopher C AU - Patterson CC AD - Center for Public Health, Queen's University, Belfast BT12 6BA, UK. FAU - Maxwell, Alexander P AU - Maxwell AP AD - Regional Nephrology Unit, Belfast City Hospital, Belfast BT9 7AB, UK ; Nephrology Research Group, Queen's University, Belfast BT9 7AB, UK. FAU - Courtney, Aisling E AU - Courtney AE AD - Regional Nephrology Unit, Belfast City Hospital, Belfast BT9 7AB, UK. LA - eng PT - Journal Article DEP - 20140924 PL - England TA - Transplant Res JT - Transplantation research JID - 101597592 PMC - PMC4178314 OTO - NOTNLM OT - Graft failure OT - Kidney transplantation OT - Re-transplantation OT - Survival EDAT- 2014/10/03 06:00 MHDA- 2014/10/03 06:01 PMCR- 2014/09/24 CRDT- 2014/10/03 06:00 PHST- 2014/08/19 00:00 [received] PHST- 2014/09/17 00:00 [accepted] PHST- 2014/10/03 06:00 [entrez] PHST- 2014/10/03 06:00 [pubmed] PHST- 2014/10/03 06:01 [medline] PHST- 2014/09/24 00:00 [pmc-release] AID - 2047-1440-3-18 [pii] AID - 10.1186/2047-1440-3-18 [doi] PST - epublish SO - Transplant Res. 2014 Sep 24;3:18. doi: 10.1186/2047-1440-3-18. eCollection 2014.